In Re Ribozyme Pharmaceuticals, Inc. Securities Litigation

Decided July 15, 2002. Marcia S. Krieger wrote the opinion for the court.

209 F. Supp. 2d 1106 · Cited 70 times

Official text

Read the full opinion (CourtListener)

We don’t host opinion text or publish a summary of this ruling — read the official public-domain text for the court’s holding and reasoning, and verify against the primary source.

Precedents cited

Decisions in our collection this opinion relies on, ordered by how often it cites each. Cases we publish link through; others open the full text.

• In Re Ribozyme Pharmaceuticals, Inc. SEC. Lit. · 119 F. Supp. 2d 1156

Cited by

Later opinions in our collection that cite this decision.

• Murphy v. Gardner · 413 F. Supp. 2d 1156
• Robinson v. Board of Regents of the University of Colorado · 390 F. Supp. 2d 1011
• Felix v. City and County of Denver · 729 F. Supp. 2d 1243
• Wausau Business Insurance v. US Motels Management, Inc. · 341 F. Supp. 2d 1180
• Rexrode v. Allstate Indemnity Co. · 616 F. Supp. 2d 1106
• Allstate Insurance v. Von Metzger · 774 F. Supp. 2d 1157
• Agile Safety Variable Fund, L.P. v. RBS Citizens, N.A. · 793 F. Supp. 2d 1248
• Bristol Co. Ltd. Partnership v. Bosch Rexroth Inc. · 758 F. Supp. 2d 1172
• SAYED v. Profitt · 743 F. Supp. 2d 1217

Explore from here

Marcia S. Krieger’s Judicial Record · D. Colorado · How we source opinions

Source: opinion metadata, authorship, and citation counts from the Free Law Project’s CourtListener bulk data (public domain). Data last verified 2026-07-09. Informational only; verify against the primary source before relying. Not a consumer report (FCRA).